Intraoral reduction of the masseter muscle and overlying mandibular bone, typically performed for benign masseteric hypertrophy through an incision inside the mouth.
Verified May 8, 2026 · 6 sources ↓
- Medicare
- $369.75
- Total RVUs
- 11.07
- Global, days
- 90
- Region
- Other
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 6 cited references ↓
- Specify intraoral approach explicitly — do not just note 'standard approach'; audit teams flag operative notes lacking route of access
- Document the clinical indication with specificity: benign masseteric hypertrophy confirmed by clinical exam and, where obtained, imaging or EMG findings
- Record functional impairment if present (e.g., trismus, pain on mastication, occlusal disruption) to support medical necessity when billing payers
- Include pre-operative measurements or photographs documenting masseter size or facial asymmetry if available
- Note the extent of muscle and bone reduction performed, including whether osteoplasty of the mandibular angle was included
- Document failure or inadequacy of conservative management if required by payer policy
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 6 cited references ↓
CPT 21296 covers intraoral reduction of the masseter muscle and associated bone — the approach that distinguishes it from 21295, which uses an extraoral incision. The procedure is most commonly performed for benign masseteric hypertrophy, where an enlarged masseter creates a prominent square-jaw contour. Access through the oral mucosa avoids visible external scarring and defines the code family split: 21295 (extraoral) versus 21296 (intraoral).
The 90-day global period applies. All routine post-operative management, including swelling, occlusion checks, and incision care, is bundled through day 90. Any separately identifiable E/M during that window requires modifier 24. If a second procedure becomes necessary — planned or unplanned, related or unrelated — apply modifier 78 (unplanned, related) or 79 (unrelated) accordingly.
Payer coverage for this procedure varies significantly by indication. When performed purely for cosmetic jaw-slimming, it is not covered by Medicare or most commercial plans. When documented as treatment for functionally impairing benign masseteric hypertrophy — causing trismus, pain, or significant occlusal dysfunction — coverage is possible but requires robust medical necessity documentation and a supporting ICD-10 diagnosis. Verify individual payer policy before scheduling.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 4.66 |
| Practice expense RVU | 5.74 |
| Malpractice RVU | 0.67 |
| Total RVU | 11.07 |
| Medicare national rate | $369.75 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $369.75 |
HOPD (APC 5164) Hospital outpatient department | $3,387.27 |
ASC (PI A2) Ambulatory surgical center (freestanding) | $1,480.50 |
Common denial reasons
The recurring reasons claims for CPT 21296 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Cosmetic exclusion: claim denied when documentation does not establish functional impairment or medical necessity beyond aesthetic improvement
- Wrong approach code billed: 21295 (extraoral) submitted when operative note describes intraoral access, or vice versa
- Missing or insufficient ICD-10 linkage: claim lacks a diagnosis code that supports the indication (e.g., benign masseteric hypertrophy) or uses an unspecified code when a specific one is available
- Global period conflict: post-operative E/M billed without modifier 24 during the 90-day global window
- Prior authorization not obtained: many payers require pre-authorization for this procedure regardless of indication
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What is the difference between CPT 21295 and 21296?
02Is CPT 21296 covered by Medicare?
03What global period applies to 21296?
04When does modifier 78 apply during the 21296 global period?
05Does 21296 require prior authorization?
06Can 21296 be billed on the same day as other craniofacial procedures?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/medicare/coding-billing/national-correct-coding-initiative-ncci-edits
- 03cms.govhttps://www.cms.gov/files/document/2025nccimedicarepolicymanualcompletepdf.pdf
- 04premera.comhttps://www.premera.com/medicalpolicies/9.02.501.pdf
- 05aapc.comhttps://www.aapc.com/codes/cpt-codes/21296
- 06mdclarity.comhttps://www.mdclarity.com/cpt-code/21296
Mira AI Scribe
Mira's AI scribe captures the surgical approach (intraoral), the extent of masseter muscle and bone reduction, the documented indication (e.g., benign masseteric hypertrophy with functional symptoms), and any intraoperative findings affecting the scope of work. This prevents the most common audit flag — operative notes that lack explicit approach documentation — and supports medical necessity defense when payers challenge cosmetic exclusion.
See how Mira captures CPT 21296 documentation